The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in Mice
Open Access
- 10 April 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 125 (14), 1757-1764
- https://doi.org/10.1161/circulationaha.111.067801
Abstract
Background— Diet-induced obesity is associated with metabolic heart disease characterized by left ventricular hypertrophy and diastolic dysfunction. Polyphenols such as resveratrol and the synthetic flavonoid derivative S17834 exert beneficial systemic and cardiovascular effects in a variety of settings including diabetes mellitus and chronic hemodynamic overload. Methods and Results— We characterized the structural and functional features of a mouse model of diet-induced metabolic syndrome and used the model to test the hypothesis that the polyphenols prevent myocardial hypertrophy and diastolic dysfunction. Male C57BL/6J mice were fed a normal diet or a diet high in fat and sugar (HFHS) with or without concomitant treatment with S17834 or resveratrol for up to 8 months. HFHS diet–fed mice developed progressive left ventricular hypertrophy and diastolic dysfunction with preservation of systolic function in association with myocyte hypertrophy and interstitial fibrosis. In HFHS diet–fed mice, there was increased myocardial oxidative stress with evidence of oxidant-mediated protein modification via tyrosine nitration and 4-OH-2-nonenol adduction. HFHS diet–fed mice also exhibited increases in plasma fasting glucose, insulin, and homeostasis model assessment of insulin resistance indicative of insulin resistance. Treatment with S17834 or resveratrol prevented left ventricular hypertrophy and diastolic dysfunction. For S17834, these beneficial effects were associated with decreases in oxidant-mediated protein modifications and hyperinsulinemia and increased plasma adiponectin. Conclusions— Resveratrol and S17834 administered concurrently with a HFHS diet prevent the development of left ventricular hypertrophy, interstitial fibrosis, and diastolic dysfunction. Multiple mechanisms may contribute to the beneficial effects of the polyphenols, including a reduction in myocardial oxidative stress and related protein modifications, amelioration of insulin resistance, and increased plasma adiponectin. The polyphenols resveratrol and S17834 may be of value in the prevention of diet-induced metabolic heart disease.Keywords
This publication has 39 references indexed in Scilit:
- Up-regulation of Adiponectin by ResveratrolJournal of Biological Chemistry, 2011
- Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imagingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARγ-dependent autocrine mechanismAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The Metabolic Syndrome and Cardiovascular RiskJournal of the American College of Cardiology, 2010
- Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in RatsJournal of Nutrition, 2010
- Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosisDiabetologia, 2010
- Cardiac-Specific Overexpression of Catalase Identifies Hydrogen Peroxide-Dependent and -Independent Phases of Myocardial Remodeling and Prevents the Progression to Overt Heart Failure in Gαq-Overexpressing Transgenic MiceCirculation: Heart Failure, 2010
- Left-Ventricular Structural and Functional Remodeling in the Mouse after Myocardial Infarction: Assessment with the Isovolumetrically-contracting Langendorff HeartJournal of Molecular and Cellular Cardiology, 1998
- Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and miceMetabolism, 1995
- Regional fat distribution and metabolism in a new mouse model () of non-insulin-dependent diabetes mellitusMetabolism, 1993